Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma

(MedPage Today) — TORONTO — A three-drug combination involving the B-cell maturation antigen (BCMA)-CD3 bispecific antibody elranatamab (Elrexfio) was associated with high response rates and manageable toxicity in newly diagnosed, transplant…

Source link : https://www.medpagetoday.com/meetingcoverage/ims/117536

Author :

Publish date : 2025-09-18 21:03:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma

Starting HRT in early menopause may reduce women’s risk of Alzheimer’s

New Blood Tests for Early Cancer Detection Get Some Love From House Members

Related Posts

Psoriasis Patients Could Benefit From GLP-1 Therapy

Trump Administration Moves to Close ‘Failing’ Organ Donation Agency

Mounjaro Found Safe, Effective in Kids With Type 2 Diabetes

New Blood Tests for Early Cancer Detection Get Some Love From House Members

Starting HRT in early menopause may reduce women’s risk of Alzheimer’s

Texas Has a New Abortion Pill Law, but One Provider Plans to Keep Sending Them There

Psoriasis Patients Could Benefit From GLP-1 Therapy

Trump Administration Moves to Close ‘Failing’ Organ Donation Agency

Mounjaro Found Safe, Effective in Kids With Type 2 Diabetes

New Blood Tests for Early Cancer Detection Get Some Love From House Members

Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma

Starting HRT in early menopause may reduce women’s risk of Alzheimer’s

Texas Has a New Abortion Pill Law, but One Provider Plans to Keep Sending Them There

Doctor’s Speech to ACIP; MD Attends the Emmys; IV Tip for Clinician Rookies

Categories

Archives